Iron deficiency, with or without anemia, is the most frequent hematological manifestation in
individuals with cancer, and is especially common in patients with colorectal cancer. Iron is a …

Iron deficiency is frequent in patients with chronic inflammatory conditions (eg, chronic heart
failure, chronic kidney disease, cancers, and bowel inflammatory diseases). Indeed, high …

Background A third of patients with colorectal cancer who are eligible for surgery in high-
income countries have concomitant anaemia associated with adverse outcomes. We aimed …

Colorectal cancer (CRC) is one of the most common cancers of the digestive tract, and
patients with advanced-stage cancer have poor survival despite the use of multidrug …

Introduction Anemia is associated with increased postoperative morbidity and mortality in
abdominal surgery. In clinical trials, preoperative iv iron treatment increases the …

BACKGROUND The role of oxidative stress in the pathogenesis of colorectal carcinoma
(CRC) has garnered considerable interest recently. Specific oxidative factors have been …

This study examines the impact of zinc, copper, cobalt, iron, and manganese on cancer
development, considering their dual roles as potential promoters or inhibitors within …

Preoperative anaemia commonly affects 30–60 per cent of the general surgical population,
and is associated with an increased risk of postoperative morbidity, prolonged hospital stay …

Background Use of the faecal immunochemical test (FIT) to triage patients with iron
deficiency (ID) for colonoscopy due to suspected colorectal cancer (CRC) may improve …

Background and Objectives: Iron is an essential micronutrient for many biological functions
and has been found to be intimately linked to cancer biology. Although the effects of …